Abstract
Non-steroidal anti-inflammatory agents (NSAIDS) are well recognised cause of hepatotoxicity. Diclofenac, a relatively new NSAID, was first introduced into the UK in 1979. Five cases of hepatitis have recently been reported, principally in the French literature. We report the first fulminant case of hepatitis in the English literature in a patient taking diclofenac and indomethacin.
| Original language | English |
|---|---|
| Pages (from-to) | 1390-1393 |
| Number of pages | 4 |
| Journal | Gut |
| Volume | 27 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 1986 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Fatal hepatitis associated with diclofenac'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver